What is it about?
The original preclinical Alzheimer's cognitive composite (PACC) was developed for in-person administration to capture subtle cognitive decline. We created a remote-friendly cognitive composite for identifying cognitive differences in older adults. We showed that this new test, administered via phone or video, is as reliable as in-person tests and correlates with key brain health markers, making it effective for remote participant evaluations.
Featured Image
Why is it important?
Our study developed a telehealth-compatible cognitive composite (tPACC) to detect subtle cognitive differences in Alzheimer's. We found that tPACC, whether administered in-person or remotely, aligns well with the original composite and is linked to key imaging biomarkers, supporting its reliability for remote assessments.
Read the Original
This page is a summary of: Examining a Preclinical Alzheimer’s Cognitive Composite for Telehealth Administration for Reliability Between In-Person and Remote Cognitive Testing with Neuroimaging Biomarkers, Journal of Alzheimer’s Disease, May 2024, IOS Press,
DOI: 10.3233/jad-231435.
You can read the full text:
Contributors
The following have contributed to this page







